Code | 51867 | ||||||||||
MA number | 14/0151/08-S | ||||||||||
Product Form: | tbl mnd 98x4 mg (blis.Al/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister Al/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 24.07.2008 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
PIL: | PIL_Montelukast Teva 4mg_12_2022.pdf |
SPC: | SPC_Montelukast Teva 4mg_12_2022.pdf |
Safety feature | Yes |
Data update: | 08.03.2018 |